Prevalence of Renal Impairment in a US Commercially Insured Rheumatoid Arthritis Population: A Retrospective Analysis.

Giles, Jon T; Simon, Lee S; Pope, Janet; Paik, Jim S; Grabner, Michael; Quebe, Amanda; Kannowski, Carol L; Salinas, Claudia A; Curtis, Jeffrey R

Giles, Jon T; Simon, Lee S; Pope, Janet; Paik, Jim S; Grabner, Michael; Quebe, Amanda; Kannowski, Carol L; Salinas, Claudia A; Curtis, Jeffrey R.

Afiliação

Giles JT; Division of Rheumatology, College of Physicians and Surgeons, Columbia University, 630 W 168th St P&S Building, Suite 3-450, New York, NY, 10032, USA. jtg2122@cumc.columbia.edu.
Simon LS; SDG LLC, Cambridge, MA, USA.
Pope J; Division of Rheumatology, University of Western Ontario, London, ON, Canada.
Paik JS; Eli Lilly and Company, Indianapolis, IN, USA.
Grabner M; HealthCore, Inc, Wilmington, DE, USA.
Quebe A; Eli Lilly and Company, Indianapolis, IN, USA.
Kannowski CL; Eli Lilly and Company, Indianapolis, IN, USA.
Salinas CA; Eli Lilly and Company, Indianapolis, IN, USA.
Curtis JR; Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, USA.

Rheumatol Ther ; 8(3): 1383-1391, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34319539

Palavras-chave

Estimated glomerular filtration rate; MDRD; Real-world evidence; Renal impairment; Rheumatoid arthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Rheumatol Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google